A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer - No Study Results Posted

A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer (BNIT-PR-001)

This study is ongoing, but not recruiting participants.

Study NCT00629057 Information provided by BN ImmunoTherapeutics

First Received: February 25, 2008 Last Updated: May 13, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	August 2009
Estimated Primary Completion Date:	December 2008 (Final data collection date for primary outcome measure)